Stock Market
Wave Life Sciences Pipeline Review Boosts Stock Price Target
By Bullbit Editorial ยท March 30, 2026
- WhatWave Life Sciences stock price target increased by Canaccord Genuity.
- WhyAnalysts reviewed the company's pipeline, finding strong potential for growth.
- SignalStrong pipeline review indicates a positive outlook for the company.
- TargetCanaccord Genuity sets a new price target of $52 for Wave Life Sciences.
- RiskInvestors should weigh the potential risks and rewards of investing in Wave Life Sciences.
More breaking news โ